First Time Loading...

Cigna Corp
NYSE:CI

Watchlist Manager
Cigna Corp Logo
Cigna Corp
NYSE:CI
Watchlist
Price: 353.4475 USD -0.3%
Updated: Apr 26, 2024
Section:
 

Wall Street
Price Targets

CI Price Targets Summary
Cigna Corp

Wall Street analysts forecast CI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CI is 390.8058 USD with a low forecast of 351.48 USD and a high forecast of 441 USD.

CI Lowest Forecast
Wall Street Target
351.48 USD
1% Downside
CI Average Forecast
Wall Street Target
390.8058 USD
11% Upside
CI Highest Forecast
Wall Street Target
441 USD
25% Upside
Lowest
Price Target
351.48 USD
1% Downside
Average
Price Target
390.8058 USD
11% Upside
Highest
Price Target
441 USD
25% Upside

CI Last Price Targets
Cigna Corp

The latest public price target was made on Feb 5, 2024 by Ben Hendrix from RBC Capital , who expects CI stock to rise by 0% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Ben Hendrix
RBC Capital
354 USD
Upside 0%
2 months ago
Feb 5, 2024
Cigna 'Top Pick for 2024': Analysts Change Ratings, Forecasts Following 2024 Guidance
Benzinga
Ann Hynes
Mizuho Securities
370 USD
Upside 5%
2 months ago
Feb 5, 2024
Cigna 'Top Pick for 2024': Analysts Change Ratings, Forecasts Following 2024 Guidance
Benzinga
Sarah James
Raymond James
372 USD
Upside 5%
2 months ago
Feb 5, 2024
Cigna 'Top Pick for 2024': Analysts Change Ratings, Forecasts Following 2024 Guidance
Benzinga
Unknown Analyst
Leerink Partners
335 USD
Downside 5%
1 year ago
Feb 8, 2023
SVB Leerink Maintains Market Perform on Cigna, Raises Price Target to $335
Benzinga
Unknown Analyst
Raymond James
350 USD
Downside 1%
1 year ago
Feb 7, 2023
Raymond James Maintains Outperform on Cigna, Lowers Price Target to $350
Benzinga
Unknown Analyst
Stephens
370 USD
Upside 5%
1 year ago
Feb 6, 2023
Stephens & Co. Maintains Overweight on Cigna, Lowers Price Target to $370
Benzinga
Show More Price Targets
Show Less Price Targets
Ben Hendrix
RBC Capital
Price Target 354 USD
Upside/Downside 0%
View Source
Ann Hynes
Mizuho Securities
Price Target 370 USD
Upside/Downside 5%
View Source
Sarah James
Raymond James
Price Target 372 USD
Upside/Downside 5%
View Source
Unknown Analyst
Leerink Partners
Price Target 335 USD
Upside/Downside 5%
View Source
Unknown Analyst
Raymond James
Price Target 350 USD
Upside/Downside 1%
View Source
Unknown Analyst
Stephens
Price Target 370 USD
Upside/Downside 5%
View Source
Show More Price Targets
Show Less Price Targets
Cigna Corp Competitors:
Price Targets
Q
QIPT
Quipt Home Medical Corp
82% Upside
PRVA
Privia Health Group Inc
58% Upside
VMD
Viemed Healthcare Inc
78% Upside
AMN
AMN Healthcare Services Inc
35% Upside
Q
QIPT
Quipt Home Medical Corp
82% Upside
PRVA
Privia Health Group Inc
58% Upside
VMD
Viemed Healthcare Inc
78% Upside
AMN
AMN Healthcare Services Inc
35% Upside
RDNT
RadNet Inc
12% Upside
CHE
Chemed Corp
23% Upside
T
5G3
Talkmed Group Ltd
59% Upside
M
MAP
Microba Life Sciences Ltd
115% Upside

Revenue
Forecast

Revenue Estimate
Cigna Corp

For the last 8 years the compound annual growth rate for Cigna Corp's revenue is 23%. The projected CAGR for the next 3 years is 13%.

23%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cigna Corp

For the last 8 years the compound annual growth rate for Cigna Corp's net income is 12%. The projected CAGR for the next 3 years is 26%.

12%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-16%
Average Miss
What are analyst estimates?

See Also

Summary
CI intrinsic value, competitors valuation, and company profile.
DCF Valuation
CI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CI stock valuation using valuation multiples.
Wall Street Estimates
CI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CI's stock price target?
Price Target
390.8058 USD

According to Wall Street analysts, the average 1-year price target for CI is 390.8058 USD with a low forecast of 351.48 USD and a high forecast of 441 USD.

What is Cigna Corp's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Cigna Corp's revenue is 23%. The projected CAGR for the next 3 years is 13%.

What is Cigna Corp's Net Income forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Cigna Corp's net income is 12%. The projected CAGR for the next 3 years is 26%.

ALPHA SPREAD
Join more than 131,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.